CHRISTINA SHERER: Open Payments
NPI 1477071629 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,179 in 89 payments from 9 companies in 2025. Trend: 2023 $564 · 2024 $1,479 · 2025 $2,179
Food & beverage: $2,080Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $461 |
| Janssen Biotech, Inc. | 15 | $428 |
| Regeneron Healthcare Solutions, Inc. | 8 | $278 |
| Madrigal Pharmaceuticals | 10 | $261 |
| Phathom Pharmaceuticals, Inc. | 10 | $224 |
| Ardelyx, Inc. | 8 | $172 |
| Gilead Sciences, Inc. | 4 | $155 |
| GENZYME CORPORATION | 1 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $92 |
Products named: TREMFYA, DUPIXENT, REZDIFFRA, VOQUEZNA, RINVOQ, IBSRELA, Livdelzi, ENTYVIO.
Industry payments across AL — which companies pay providers there.
